Market Research Logo

North America Drugs for Malaria Market by Manufacturers, Countries, Type and Application, Forecast to 2023

North America Drugs for Malaria Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease."

Scope of the Report:
This report focuses on the Drugs for Malaria in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Market Segment by Countries, covering
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Market Segment by Type, covers
Prevention
Treatment
Other

Market Segment by Applications, can be divided into
Prevention
Treatment
Other

There are 15 Chapters to deeply display the North America Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Drugs for Malaria, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Drugs for Malaria market forecast, by countries, type and application, with sales, price and revenue, from 2018 to 2023;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source


1 Market Overview
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Mexico Status and Prospect (2013-2023)
1.4.3 Canada Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cipla
2.1.1 Business Overview
2.1.2 Drugs for Malaria Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Guilin Pharmaceutical
2.2.1 Business Overview
2.2.2 Drugs for Malaria Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 IPCA Laboratories
2.3.1 Business Overview
2.3.2 Drugs for Malaria Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Drugs for Malaria Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan Labs
2.5.1 Business Overview
2.5.2 Drugs for Malaria Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Drugs for Malaria Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Drugs for Malaria Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi Aventis
2.8.1 Business Overview
2.8.2 Drugs for Malaria Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ajanta Pharma
2.9.1 Business Overview
2.9.2 Drugs for Malaria Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America Drugs for Malaria Market Competition, by Manufacturer
3.1 North America Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
3.1.1 North America Drugs for Malaria Sales by Manufacturer (2016-2017)
3.1.2 North America Drugs for Malaria Sales Market Share by Manufacturer (2016-2017)
3.2 North America Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America Drugs for Malaria Revenue by Manufacturer (2016-2017)
3.2.2 North America Drugs for Malaria Revenue Market Share by Manufacturer (2016-2017)
3.3 North America Drugs for Malaria Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America Drugs for Malaria Market Analysis by Countries
4.1 North America Drugs for Malaria Sales and Market Share by Countries (2013-2018)
4.1.1 North America Drugs for Malaria Sales by Countries (2013-2018)
4.1.2 North America Drugs for Malaria Sales Market Share by Countries (2013-2018)
4.2 North America Drugs for Malaria Revenue (Value) and Market Share by Countries (2013-2018)
4.2.1 North America Drugs for Malaria Revenue by Countries (2013-2018)
4.2.2 North America Drugs for Malaria Revenue Market Share by Countries (2013-2018)
5 North America Market Segmentation Drugs for Malaria by Type
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America Drugs for Malaria Sales and Market Share by Type (2013-2018)
5.1.2 North America Drugs for Malaria Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price
5.2 Aryl Aminoalcohol Compounds Sales Growth and Price
5.2.1 North America Aryl Aminoalcohol Compounds Sales Growth (2013-2018)
5.2.2 North America Aryl Aminoalcohol Compounds Price (2013-2018)
5.3 Antifolate Compounds Sales Growth and Price
5.3.1 North America Antifolate Compounds Sales Growth (2013-2018)
5.3.2 North America Antifolate Compounds Price (2013-2018)
5.4 Artemisinin Compounds Sales Growth and Price
5.4.1 North America Artemisinin Compounds Sales Growth (2013-2018)
6 North America Market Segmentation Drugs for Malaria by Application
6.1 North America Drugs for Malaria Sales Market Share by Application (2013-2018)
6.2 Prevention Sales Growth (2013-2018)
6.3 Treatment Sales Growth (2013-2018)
6.4 Other Sales Growth (2013-2018)
7 United States Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Drugs for Malaria Sales and Market Share by Type
7.2.1 United States Drugs for Malaria Sales by Type (2013-2018)
7.2.2 United States Drugs for Malaria Sales Market Share by Type (2013-2018)
7.3 United States Drugs for Malaria Sales and Market Share by Application (2013-2018)
7.3.1 United States Drugs for Malaria Sales by Application (2013-2018)
7.3.2 United States Drugs for Malaria Sales Market Share by Application (2013-2018)
7.4 United States Drugs for Malaria Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Drugs for Malaria Export and Import (2013-2018)
8 Canada Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
8.2 Canada Drugs for Malaria Sales and Market Share by Type (2013-2018)
8.2.1 Canada Drugs for Malaria Sales by Type (2013-2018)
8.2.2 Canada Drugs for Malaria Sales Market Share by Type (2013-2018)
8.3 Canada Drugs for Malaria Sales and Market Share by Application (2013-2018)
8.3.1 Canada Drugs for Malaria Sales by Application (2013-2018)
8.3.2 Canada Drugs for Malaria Sales Market Share by Application (2013-2018)
8.4 Canada Drugs for Malaria Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 Canada Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
8.4.2 Canada Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
8.5 Canada Drugs for Malaria Export and Import (2013-2018)
9 Mexico Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
9.2 Mexico Drugs for Malaria Sales and Market Share by Type (2013-2018)
9.2.1 Mexico Drugs for Malaria Sales by Type (2013-2018)
9.2.2 Mexico Drugs for Malaria Sales Market Share by Type (2013-2018)
9.3 Mexico Drugs for Malaria Sales and Market Share by Application (2013-2018)
9.3.1 Mexico Drugs for Malaria Sales by Application (2013-2018)
9.3.2 Mexico Drugs for Malaria Sales Market Share by Application (2013-2018)
9.4 Mexico Drugs for Malaria Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Mexico Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Mexico Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
9.5 Mexico Drugs for Malaria Export and Import (2013-2018)
10 Drugs for Malaria Market Forecast (2018-2023)
10.1 North America Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
10.2 Drugs for Malaria Market Forecast by Countries (2018-2023)
10.2.1 North America Drugs for Malaria Sales Forecast by Countries (2018-2023)
10.2.2 United States Drugs for Malaria Forecast (2018-2023)
10.2.3 Canada Drugs for Malaria Forecast (2018-2023)
10.2.4 Mexico Drugs for Malaria Forecast (2018-2023)
10.3 Drugs for Malaria Market Forecast by Type (2018-2023)
10.3.1 North America Drugs for Malaria Sales Forecast by Type (2018-2023)
10.3.2 North America Drugs for Malaria Market Share Forecast by Type (2018-2023)
10.4 Drugs for Malaria Market Forecast by Application (2018-2023)
10.4.1 North America Drugs for Malaria Sales Forecast by Application (2018-2023)
10.4.2 North America Drugs for Malaria Market Share Forecast by Application (2018-2023)
11 Drugs for Malaria Manufacturing Cost Analysis
11.1 Drugs for Malaria Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Malaria
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Malaria Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2017
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report